Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-18425
Bilsen, J; Norup, M; Deliens, L; Miccinesi, G; van der Wal, G; Löfmark, R; Faisst, K; van der Heide, A (2006). Drugs used to alleviate symptoms with life shortening as a possible side effect: end-of-life care in six European countries. Journal of Pain and Symptom Management, 31(2):111-121.
|PDF - Registered users only|
We investigated the drugs used in the alleviation of pain and symptoms (APS) with a possible life-shortening side effect in six European countries' end-of-life care. We sent mail questionnaires to physicians who signed a representative sample of death certificates in each country. APS with a possible life-shortening effect occurred from 19% of all deaths in Italy to 26% in Denmark. Physicians usually administered opioids (from 76% of APS cases in Italy to 96% in The Netherlands), but the type of opioids and administration practice differed markedly between countries. The doses of opioids given in the last 24 hours also varied significantly and were usually lower than 300 mg oral morphine equivalent (from 83% of cases in Belgium to 93% in Sweden). The highly variable results bring into question whether existing guidelines for pain relief were applied appropriately and to what extent unfounded concerns about the possible life-shortening effect of opioids resulted in less than optimal symptom management in end-of-life care.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > Institute of Social and Preventive Medicine|
|DDC:||610 Medicine & health|
|Deposited On:||23 Apr 2009 14:40|
|Last Modified:||11 Jan 2013 08:36|
|WoS Citation Count:||24|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page